3-4 independent mouse experiments, while data (means) at week 3, 6 and 104 are from one experiment evaluated in duplicate. *P < 0.05, **P < 0.01 and ***P < 0.001 comparing responses of i.n. and s.c.
BCG using one-way ANOVA followed by Bonferroni's post-test. (b) Representative flow-cytometric 3 plots from one experiment showing nApa or WCL-specific IFN-γ, IL-2 and/or TNF-α expression by CD8 + T cells in the lung at the peak of response (week 32) after s.c. BCG vaccination. s.c., subcutaneous; i.n., intranasal; Ag, antigen; WCL, whole cell lysate of Mtb. Figure S2 . Timing, route and form of a subunit-Apa-boost in the BCG-primed mice impact the cellular booster response
Mice were primed with BCG vaccine by the i.n. or s.c. route and boosted with a subunit nApa or rApa (10µg) vaccine using a DDA/MPL adjuvant by a homologous or heterologous route at the peak (8 months) or contraction-phase (16 months) of BCG-elicited response. In one experiment, i.n. BCGprimed mice were boosted with a DDA/MPL adjuvant alone by a homologous i.n. route during the contraction-phase. Three weeks after a subunit vaccine-or adjuvant-boost, frequencies of antigenspecific cytokine-producing cells in the lung, CLN or spleen (pooled) were determined using a cultured cytokine response using pooled organ cells in triplicate cultures (n= 4mice/group/time point). Significant using ANOVA followed by Bonferroni's post-test. *P < 0.05, **P < 0.01 and ***P < 0.001. s.c., subcutaneous; i.n., intranasal; vac, vaccine; WCL, whole cell lysate of Mtb; SFU, spot forming units. (a) The magnitude and kinetics of cytokine-producing cells in rApa vaccinated mice. Six-eight-week old mice were subunit immunized three times with rApa (10µg/dose) in a DDA-MPL adjuvant at 2-week intervals by the i.n. route, and IFN-γ, IL-2, IL-4 and IL-17 responses were investigated in the lung and spleen as indicated using a cultured ELISPOT assay. Data are mean ± s.d. of triplicate cultures using 5 pooled cells (n = 4 mice/time point). The IL-2 response was not investigated at the 2-week time point.
Significant waning of cytokine response at the week 32 compared to the 2-week time point using a one- Bonferroni's test compared to the respective control group. *P < 0.05, **P < 0.01 and ***P < 0.001.
i.n., intranasal; vac, vaccine; WCL, whole cell lysate of Mtb; SFU, spot forming units. triplicate culture. ANOVA followed by Bonferroni's test. *P < 0.05, **P < 0.01 and ***P < 0.001. s.c., subcutaneous; mo, months; vac, vaccine; WCL, whole cell lysate of Mtb; SFU, spot forming units.
7 Figure S5 . T-cell clones generated by a subunit nApa vaccination express an IL-2-producing phenotype.
BALB/c mice were vaccinated using a single dose of nApa (40 µg) in the Freund's incomplete adjuvant and the T-cell hybridomas were generated using a draining lymph node cells. Individual T-cell clones responding to nApa were purified by a serial dilution and tested for a reactivity to the native or recombinant form of Apa using an IL-2 capture ELISA, after a co-culture with the syngeneic antigen presenting cells (APCs) pulsed with the antigen. Of the total 17 Apa-reactive hybridoma clones developed, 10 clones recognized only nApa and not rApa (a), while 7 clones recognized both nApa and rApa (b) and produced a positive IL-2 response. The IL-2 response of one clone that recognized both nApa and rApa but stopped responding consistently is not shown. The antigen dose response curve was 8 carried out using the antigen-pulsed bone marrow derived dendritic cells as APCs. For clones 5F9 and 5D8 data is available using only one antigen dose (2 µg Regardless of the timing of boost, decreased specific IgG1 antibody levels were found in the sera of nApa-boosted mice relative to levels in the corresponding non-boosted controls. Interestingly, nApaboost at the contraction-phase (16 months) increased the specific serum IgG2a and IgG2b levels, indicating the influence of the timing of a subunit nApa-boost after BCG-priming on the magnitude and quality of antibody response (b) Serum IgG response of the s.c.-i.n. regimen (in Figure 3) using ELISA.
The WCL-specific IgG1, IgG2a and IgG2b antibody levels are plotted for the nApa-boosted groups (i.e. and spleen of rApa vaccine-boosted, saline-boosted, age-matched naïve and young adult naïve (12-week-old) mice 6 weeks post-challenge shown as a box plot (n = 5-6 mice/group). Whiskers indicate maximum and minimum CFU levels. WCL, whole cell lysate of Mtb; vac, vaccine; SFU, spot forming units; CFU, colony forming units.
11 Figure S8 . Poor IL-2 response in the BCG-primed-rApa vaccine-boosted mice is not due to the inherent inability of a subunit rApa vaccine to induce specific IL-2 + CD4 + T cells.
Six-eight-week old mice were vaccinated with 3 doses of nApa or rApa (1µg/dose) in DDA/MPL adjuvant at 4-week intervals by a s.c. route on the hind legs. Magnitude (histograms) and quality (pie charts) of nApa-and WCL-specific total cytokine-producing (IFN-γ, IL-2 and/or TNF-α) cells among CD4 + T cells of spleen, ILN and lung were determined 4 weeks after the last subunit dose (prechallenge) and 6 weeks after Mtb challenge (post-challenge) using a flow cytometry. Significant using ANOVA followed by Bonferroni's test. Arcs surrounding pie charts denote IL-2-producing cells in any combinations of nApa-or WCL-specific CD4 + T cells (n = 4 individually analyzed mice/group). WCL, whole cell lysate of Mtb; vac, vaccine.
Supplementary methods
Vaccinations and experimental infections. Mtb H37Rv was grown to mid-log phase at 37 o C in liquid glycerol-alanine-salts (GAS) medium and culture filtrate was harvested. The nApa was purified from the culture filtrate by combinations of column chromatography techniques using Con-A-Sepharose and Phenyl-Sepharose columns, while rApa was expressed in E. coli BL21 (DE3) and purified from lysates by Nickel chromatography with endotoxin removal step followed by DEAE-Sepharose chromatography. 14,17 Purity was confirmed by SDS-PAGE, N-terminal sequencing and by Western blot medium supplemented with 100 IU/ml penicillin, 50 µg/ml streptomycin, 1 mM L-glutamine, 25 mM HEPES, 1 mM sodium pyruvate, 5 × 10 −5 M β-mercaptoethanol, vitamins and nonessential amino acids (all Gibco-Invitrogen, Grand Island, NY) and 10% endotoxin-tested heat-inactivated FCS (Atlas Biologicals, Fort Collins, CO) as described previously. 13 Briefly, the lungs were digested with an enzyme mixture containing 1 mg/ml collagenase type IV (Sigma-Aldrich) and 25 U/ml DNase (Roche, Penzberg, Germany) in supplemented RPMI-1640 at 37°C for 1 h. The digested lung fragments, spleen or LNs were pressed through a 70-µm pore size cell strainer (BD Falcon, Bedford, MA) to obtain a single cell suspension. The erythrocytes were lysed with RBC lysis buffer (eBioscience, San Diego, CA) at 22°C, and cells were washed extensively (×4), re-suspended in supplemented RPMI-1640 and counted using an automated cell counter (Countess, Invitrogen, Carlsbad, CA) employing the trypan blue dye exclusion method.
Flow-cytometric staining and analysis. Cell surface marker and intracellular cytokine staining (ICS) was performed as described previously. 8, 17 Briefly, 2×10 6 cells were dispensed in 96 well polypropylene plates in supplemented RPMI-1640 medium and stimulated with Mtb antigen (10µg/ml) in a total volume of 200 µl. Stimulation with PMA-ionomycin (1µg/ml) was used as a positive control.
Stimulations were conducted in the presence of anti-CD28 and anti-CD49d antibodies (1µg/ml; BD Pharmingen) and the cells were incubated at 37°C in the presence of 5% CO2 for 8 h. Brefeldin A (10µg/ml) and monensin (3μM; BD pharmingen) were added and cells were cultured for additional 4 h. Approximately 500,000 lymphocytes were acquired on the LSRII system (BD Immunocytometry Systems) and analyzed using FlowJo software (Treestar, Inc., San Carlos, CA medium containing 10% FCS. Cells were stimulated with 10 µg/ml of nApa, rApa, WCL, rESAT-6, rCFP-10 or synthetic Apa peptides for 40 h. Stimulation with Con-A (1µg/ml; Sigma-Aldrich) was used as a positive control for cell viability and reactivity. After incubation at 37°C, the wells were washed with PBS-Tween-20 and the site of cytokine secretion was detected with a biotin-labeled detection antibody and horseradish peroxidase-conjugated streptavidin. The enzyme reaction was developed using 3-amino-9-ethylcarbazole (AEC) substrate reagent set (BD-Biosciences, San Diego, CA). The number of SFU per well were counted using an ELISPOT reader (Cellular Technology Limited, Cleveland, OH).
The number of spots specific for each antigen preparation was calculated by subtracting the number of spots that formed in the absence of added antigen from the number that formed in its presence. The cytokine response ≥ 50 SFU/10 6 organ cells after subtracting no antigen control values was considered a positive response.
Generation of nApa-specific T-cell hybridomas and cytokine ELISA. T-cell hybridomas specific for
Mtb nApa were generated as previously described 17 . Briefly, four BALB/c mice were each vaccinated with 40 µg of nApa in FIA by injecting 25 µl into each hind footpad and the remainder at the base of the tail. Five days after the vaccination, the draining lymph nodes (popliteal, inguinal and periaortic) were harvested to obtain LN cells. The primed LN cells were re-stimulated in vitro with syngeneic bone marrow derived dendritic cells (BMDCs) that had been pulsed with 10 µg/ml nApa per well.
Approximately 1×10 6 primed LN cells were added per well in two 24-well tissue culture plates in a total volume of 1 ml of complete RPMI 1640 medium (RPMI 1640 supplemented with 10% FCS, 5×10 −5 M 2-ME (Sigma) plus a nutrient cocktail). After two days of culture, the cells were harvested and pooled from all 48 wells, washed, fused with the T cell fusion partner BWα − β − , and plated out into ten 96-well plates. Clones that grew in individual wells were screened using either BMDCs, as above, or a BALB/c mouse-derived B cell lymphoma line A20 pulsed with 0.5µg/well nApa. The selection of responding T cell hybridomas was performed by assaying 24 h culture supernatants using paired rat mAbs specific for mouse IL-2 or IFN-γ (Pharmingen/BD-Biosciences) in a capture ELISA. For antigen presentation studies, micro-culture wells were prepared containing 250 µl of culture medium, 5×10 4 each of T cell hybridoma and antigen presenting cells (APC), and a known amount of nApa or rApa (intact or trypsin digested), in flat-bottomed 96-well micro-titer wells. Dose response curves with native and recombinant antigens were performed to determine which T cell hybridomas respond to nApa alone, or to both native and recombinant form of Apa. T cell hybridomas were further tested with a panel of synthetic, overlapping, nonglycosylated Apa peptides or trypsin digested and RP-HPLC separated nApa fractions 17 to determine the peptide epitopes that were recognized. Antigen-specific IL-2 responses of the clones were comparable regardless of APC type used for antigen presentation (i.e., bone-marrow-derived macrophages (BMDMs) versus BMDCs; data not shown).
